Forecasts data is unavailable for this security.
Consensus recommendation
- 18-May-23
- 15-Feb-24
- 14-Mar-24
- 18-Apr-24
- 25-Apr-24
Select bar for recommendation details.
Recommendations | 25-Apr-24 | |
---|---|---|
Buy | 1 | |
Outperform | 4 | |
Hold | 4 | |
Underperform | 0 | |
Sell | 0 |
Share price forecast in GBX
The 8 analysts offering 12 month price targets for Oxford BioMedica plc have a median target of 392.50, with a high estimate of 740.00 and a low estimate of 180.00. The median estimate represents a 41.95% increase from the last price of 276.50.
High | 167.6% | 740.00 |
Med | 42.0% | 392.50 |
Low | -34.9% | 180.00 |
Earnings history & estimates in GBX
Average growth rate | +9.53% |
More ▼
Revenue history & estimates in GBP
Average growth rate | +15.43% |
More ▼